Pfizer CEO Albert Bourla sold 62% of his stock in the company worth $5.56 million (₹41.4 crore) on the same day the US drugmaker reported positive data on its COVID-19 vaccine. He sold the shares at close to their highest price this year. The sale happened as Pfizer's shares hit a certain price as part of a pre-announced trading plan.